DEF 14A: GoodRx Holdings Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals

GoodRx Holdings will hold its annual stockholders meeting virtually on June 6, 2024, to vote on director elections, auditor ratification, and executive compensation.

Summary

• GoodRx Holdings, Inc. will hold its 2024 Annual Meeting of Stockholders on June 6, 2024, at 2:00 p.m. Pacific Time, as a virtual meeting.
• Stockholders of record as of April 8, 2024, are entitled to vote.
• The meeting will address the election of three Class I Directors (Douglas Hirsch, Kelly J. Kennedy, and Agnes Rey-Giraud), ratification of PricewaterhouseCoopers LLP as the independent accounting firm for the fiscal year ending December 31, 2024, and an advisory vote on executive compensation.
• The Board of Directors recommends voting in favor of all proposals.
• At the close of business on the record date, there were 94,112,823 shares of Class A common stock and 280,869,320 shares of Class B common stock issued and outstanding and entitled to vote at the Annual Meeting, representing approximately 3.2% and 96.8% of the voting power of our Common Stock, respectively.

Sentiment

Score: 7

Explanation: The document is neutral in tone, providing factual information about the upcoming annual meeting and proposals. It expresses confidence in the virtual meeting format and recommends voting in favor of the proposals.

Positives

• The virtual meeting format aims to increase stockholder attendance and participation.
• The Board recommends voting 'FOR' all proposals.

Risks

• As a controlled company, GoodRx is exempt from certain Nasdaq corporate governance requirements, which may reduce stockholder protections.
• The Stockholders Agreement gives Sponsor Stockholders control over the election of directors.

Future Outlook

The company will continue to hold advisory say-on-pay votes annually, with the next vote expected at the 2025 Annual Meeting.

Management Comments

• Trevor Bezdek, Chairman of the Board: 'Utilizing the latest technology and a virtual meeting format will allow stockholders to participate from any location and we expect will lead to increased attendance, improved communications and cost savings for our stockholders and the Company, and is a more environmentally friendly format.'

Industry Context

The document reflects standard corporate governance practices for publicly traded companies, including proxy statements, annual meetings, and executive compensation disclosures.

Comparison to Industry Standards

• The director independence standards align with Nasdaq rules, similar to other listed companies.
• The executive compensation practices, including base salary, bonus, and equity awards, are typical for companies of similar size and industry.
• The virtual meeting format is increasingly common, reflecting a trend toward greater accessibility and cost efficiency.

Stakeholder Impact

• Shareholders are encouraged to participate in the virtual annual meeting and vote on key proposals.
• The virtual meeting format aims to improve communication and reduce costs for stockholders and the company.

Next Steps

• Stockholders are urged to vote their shares by phone, internet, or mail.
• The company will announce preliminary voting results at the Annual Meeting and report final results in a Current Report on Form 8-K.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Board of Directors, Director Election, Executive Compensation, PricewaterhouseCoopers, Virtual Meeting, GoodRx